Precautions to Consider in the Analysis of Prognostic and Predictive Indices

Loïc Chartier; Aurélien Belot; Isabelle Chaillol; Mad-Hélénie Elsensohn; Cédric Portugues; Marguerite Fournier; Clémentine Joubert; Elodie Gat; Cécile Pizot; Patrick Fogarty; Tesla Murairi; Romain Ould Ammar; Jérôme Paget; Fanny Cherblanc; Romain Ricci; Laetitia Vercellino; Salim Kanoun; Anne-Ségolène Cottereau; Catherine Thieblemont; Olivier Casasnovas

doi:10.2967/jnumed.123.267021

Precautions to Consider in the Analysis of Prognostic and Predictive Indices

J Nucl Med. 2024 Nov 1;65(11):1672-1678. doi: 10.2967/jnumed.123.267021.

Authors

Loïc Chartier¹, Aurélien Belot², Isabelle Chaillol², Mad-Hélénie Elsensohn², Cédric Portugues², Marguerite Fournier², Clémentine Joubert², Elodie Gat², Cécile Pizot², Patrick Fogarty², Tesla Murairi², Romain Ould Ammar², Jérôme Paget², Fanny Cherblanc³, Romain Ricci⁴, Laetitia Vercellino⁵, Salim Kanoun⁶, Anne-Ségolène Cottereau⁷, Catherine Thieblemont⁸, Olivier Casasnovas⁹

Affiliations

¹ Biostatistics Department, LYSARC, Hôpital Lyon Sud, Pierre-Bénite, France; [email protected].
² Biostatistics Department, LYSARC, Hôpital Lyon Sud, Pierre-Bénite, France.
³ Medical Department, LYSARC, Hôpital Lyon Sud, Pierre-Bénite, France.
⁴ Imaging Department, LYSARC, Hôpital Henri-Mondor, Créteil, France.
⁵ Department of Nuclear Medicine, Hôpital Saint-Louis, AP-HP, INSERM UMR S942, Université Paris Cité, Paris, France.
⁶ Department of Hematology, Cancer Research Center of Toulouse, Team 9, INSERM Unité Mixte de Recherche 1037, Toulouse, France.
⁷ Department of Nuclear Medicine, Hôpital Cochin, AP-HP, Université Paris Cité, Paris, France.
⁸ Assistance Publique-Hôpitaux de Paris, Université de Paris, and Hemato-Oncologie, Hôpital Saint-Louis, Paris, France; and.
⁹ Department of Hematology and INSERM 1231, CHU Dijon Bourgogne, Dijon, France.

PMID: 39486863
DOI: 10.2967/jnumed.123.267021

Abstract

Understanding the differences between prognostic and predictive indices is imperative for medical research advances. We have developed a new prognostic measure that will identify the strengths, limitations, and potential applications in clinical practice.

Keywords: comparison; imaging; prognostic.

MeSH terms

Humans
Prognosis*
Statistics as Topic